What is the blood-brain barrier, and why could it hold a key to Alzheimer’s?
A new study in mice suggests the brain’s protective barrier does more than block harmful substances. It also delivers essential proteins from...
A highly accurate blood test that uses artificial intelligence to detect multiple cancers from just a few drops of blood is now entering clinical trials across the UK’s National Health Service.
A groundbreaking AI-driven blood test known as miONCO-Dx is set to begin clinical trials with the UK’s National Health Service (NHS), potentially transforming how cancer is detected and diagnosed.
Developed to identify up to 12 of the most common and deadly cancers — including bowel, breast, lung, ovarian, and pancreatic — the test boasts a reported accuracy rate of over 99%, according to Kazinform.
The new trial will involve 8,000 patients and builds on data from more than 20,000 individuals. The UK government has allocated £2.4 million in funding to support the project, which is seen as a potential breakthrough in cancer diagnostics.
Cancer remains a major global health threat, and early detection is critical. In the United States alone, it is the second leading cause of death, with more than 600,000 fatalities annually. Experts emphasize that survival rates can dramatically improve with early diagnosis — nine out of ten bowel cancer patients survive if detected at stage one, compared to just one in ten at stage four.
If successful, the miONCO-Dx test could ease pressure on overburdened healthcare systems by providing a fast, non-invasive, and highly accurate alternative to traditional diagnostic methods.
European leaders gathered in Dublin on Thursday, 12 November, for the ninth European Political Community (EPC) summit, with security, defence and energy high on the agenda. Azerbaijani President Ilham Aliyev held talks focused on peace, trade and regional cooperation.
Iran will not let a single particle of its enriched nuclear material leave the country, and any new U.S. attack would be met with strikes on distant American bases, Iranian security chief Mohsen Rezaei has said.
Nvidia chief executive Jensen Huang is stepping down amid reports linking him to a woman suspected by U.S. authorities of spying for China, throwing the future of the $4 trillion chipmaker into uncertainty.
Four million workers across Spain joined a general strike on Wednesday over the country’s deepening housing crisis, unions said, bringing disruption to factories, ports, shops and public transport just weeks before a snap general election.
Kazakhstan’s security service has arrested Nurlan Zhakupov, CEO of Samruk-Kazyna, the country’s sovereign wealth fund, on suspicion of corruption. Yelzhas Otynshiyev, Chairman of KTZ, Kazakhstan’s national railway firm has also been detained.
A new study in mice suggests the brain’s protective barrier does more than block harmful substances. It also delivers essential proteins from the body, a process that may break down early in Alzheimer’s disease and offer a new target for treatment.
Here's your AnewZ Daily Brief for the 5th of November, as health emergencies, humanitarian crises, political shifts, and cybersecurity threats put governments and essential services under pressure across the globe. Here are five stories worth your attention.
Kazakhstan plans to manufacture 494 types of medicines through eight major investment projects worth a combined $862 million, Health Minister Akmaral Alnazarova announced on 3 November, local media reported.
Dengue fever has killed more people in Bangladesh this year than in the whole of 2025, with October the deadliest month so far, data from Bangladesh's Health Ministry shows.
Visitors to Armenia could face temperature screening after a lab worker died from suspected Pneumonic plague in Russia, Yerevan’s Health Minister Anahit Avanesyan told lawmakers on Wednesday, Armenian state news agency Armenpress reported.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment